Hemarthrosis: Clinical Trials

3 trials for Hemarthrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 not yet recruiting, 1 unknown. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Active not recruiting 1, Not yet recruiting 1, Unknown 1
Phase 22Active not recruiting 1, Unknown 1

Follow Hemarthrosis: new trials by email Literature Review of Hemarthrosis trials Research Report on Hemarthrosis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction
Tranexamic Acid, Placebo - Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Phase 3Not yet recruitingDave Bernholt1002026-11-012026-10-26
Real-World Joint Outcomes After Selective Transition to Low-Dose Emicizumab in Pediatric Hemophilia A
Switching to low dose emicizumab - Hemophilia A Patient
Phase 2 / Phase 3Active not recruitingChulalongkorn University182025-06-012026-02-27
Comparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia A
"Emicizumab", "HEMLIBRA®" - Severe Hemophilia A Without Inhibitor, Joint Bleed
Phase 2 / Phase 3UnknownChulalongkorn University152023-06-222024-03-05

Narrower conditions

Hemophilia A (2)  ·  Anterior Cruciate Ligament Injuries (1)  ·  Pain (1)  ·  Pain, Postoperative (1)

Broader conditions

Hemorrhage (3)  ·  Joint Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Blood Coagulation Disorders (2)  ·  Blood Coagulation Disorders, Inherited (2)  ·  Coagulation Protein Disorders (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Hemorrhagic Disorders (2)  ·  Knee Injuries (1)  ·  Leg Injuries (1)

Interventions

emicizumab (2)  ·  Tranexamic Acid (1)

Sponsors

Chulalongkorn University (2)  ·  Dave Bernholt (1)

Countries

Thailand (2)  ·  United States (1)

Results publications

PMID 39737816